Garonit Pharmaceutical, an India-based API maker, plans to build a $46.1 million production plant in New York to produce ...

Measures intended to punish elite universities are inflicting collateral damage on the nation’s two-year colleges, which ...

The deal disrupts a long-established practice of the exemption of medicines from tariffs due to their importance in public ...

For outsourcing and manufacturing professionals, 2024 may be remembered as the year capacity and partnerships took center ...